Fourteen years ago, I got the news that I had cancer. It was in both breasts. My colleagues were there for me all the way. Then, after nine months, my treatment ended, and I went back to work as a family doctor, but things were different. I was fragile. I had a new body. I was living with a newly diagnosed BRCA gene mutation that put me at high risk of breast and ovarian cancer. I required a prophylactic hysterectomy and breast reconstruction, making choices that would impact me and my family. The psychological impact was massive.

People have known about breast cancer since ancient times.  For most of that time, there were no effective treatments.  However, in the last 120 years, advances in surgical and medical treatments have meant that today, 98 percent of patients with localized breast cancer survive at least five years after diagnosis.  The following timeline shows the development of breast cancer treatments.

Every year clinicians, researchers, patient advocates and industry members head to Texas to share the latest breakthroughs in breast cancer research. It’s a key conference to learn about new treatments or new standards of care for breast cancer patients. Here’s some of the highlights that have the most impact on patient care today: